Syros Pharmaceuticals Inc SYRS
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.01 / $0.09
- Shares Outstanding
- 26.83M
- Market Cap
- $10,732.98
- Volume/Avg
- 11,447 / 9,453
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 68
- Website
- https://www.syros.com
Valuation
|
Metric
|
SYRS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
SYRS
Financial Strength
|
Metric
|
SYRS
|
|---|---|
Quick Ratio | 2.05 |
Current Ratio | 2.25 |
Interest Coverage | −18.23 |
Quick Ratio
SYRS
Profitability
|
Metric
|
SYRS
|
|---|---|
Return on Assets (Normalized) | −81.53% |
Return on Equity (Normalized) | −1,036.20% |
Return on Invested Capital (Normalized) | −145.58% |
Return on Assets
SYRS
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|>$tCxG# | LOCK|!zf? | $134B | |||
| Moderna Inc
MRNA
| LOCK|Tl@QD& | LOCK|&ry | $86B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|J?sK#Lm | LOCK|$!pn | $84B | |||
| argenx SE ADR
ARGX
| LOCK|R^&Gnhv | LOCK|Nn | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|>yrQ^Z | LOCK|r% | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|HN<N&<? | LOCK|fwncr | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|rgV^cM? | LOCK|LLRDb | $29B | |||
| Incyte Corp
INCY
| LOCK|!@&MXsb | LOCK|YP | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|HpWzC%d | LOCK|%X | $22B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|WpZ?HlN | LOCK|<V | $14B |
United States